Comparison of Dual vs. Triple Antithrombotic Therapy in Non-Valvular AF and Acute Coronary Syndrome: A Malaysian Cohort Study

Authors

  • Eldowaik Mohamed Salah Saad University of Cyberjaya, Selangor, Malaysia
  • Zainol Akbar Zainal University of Cyberjaya, Selangor, Malaysia
  • Shairyzah Ahmed Hisham University of Cyberjaya, Selangor, Malaysia
  • Sahimi Mohamed Hospital Sultan Idris Shah, Serdang, Malaysia
  • Pavithira Devi Hospital Sultan Idris Shah, Serdang, Malaysia

DOI:

https://doi.org/10.47144/phj.v57i1.2666

Abstract

Objectives: This study aimed to compare Dual Antithrombotic Therapy (DAT) and Triple Antithrombotic Therapy (TAT) concerning bleeding and thrombosis outcomes in Malaysian patients with non-valvular atrial fibrillation (NVAF) and acute coronary syndrome (ACS), considering demographic characteristics and comorbidities.

Methodology: A retrospective observational cohort study was conducted at Hospital Serdang from January 1, 2020, to May 1, 2022. A total of 206 patients were selected via purposive sampling and divided into two groups. The TAT group received warfarin, clopidogrel, and aspirin, while the DAT group received warfarin and clopidogrel over a 1-year follow-up. Multivariate logistic regression analysis was employed.

Results: A higher incidence of thromboembolic episodes was observed in the DAT group (24.3% vs. 8.7% in the TAT group; adjusted odds ratio (aOR) 4.53, 95% CI 1.806-11.379, P= 0.001), signifying a 4.5-fold increase in thromboembolic events in DAT compared to TAT. Conversely, more bleeding episodes were observed in the TAT group (25.2% vs. 15.5% in the DAT group; aOR 2.22, 95% CI 0.993-4.970, P= 0.52), although the difference was not statistically significant.

Conclusion: The DAT protocol showed significantly more thrombosis episodes than the TAT protocol, while TAT exhibited a non-significant increase in bleeding events compared to DAT at one year follow-up in patients with NVAF and ACS.

Downloads

Download data is not yet available.

Downloads

Published

2024-03-30

How to Cite

1.
Saad EMS, Zainal ZA, Hisham SA, Mohamed S, Devi P. Comparison of Dual vs. Triple Antithrombotic Therapy in Non-Valvular AF and Acute Coronary Syndrome: A Malaysian Cohort Study. Pak Heart J [Internet]. 2024Mar.30 [cited 2024Jun.16];57(1):3-8. Available from: https://pakheartjournal.com/index.php/pk/article/view/2666

Issue

Section

Original Article